Recommendations for the programming of implantable cardioverter-defibrillators in new zealand

Heart Lung and Circulation

Volumn 21, Issue 12, 2012, Pages 765-777

  Webber, Matthew R ^a   Stiles, Martin K ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Anti tachycardia pacing; Defibrillators; Implantable; Programming recommendations; Shocks; Supraventricular; Tachycardia; Ventricular fibrillation

Indexed keywords

ALGORITHM; BRUGADA SYNDROME; CARDIOMYOPATHY; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PACING; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR PROGRAMMING; LONG QT SYNDROME; NEW ZEALAND; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; REVIEW; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; SINUS TACHYCARDIA; STANDARDIZATION; SURVIVAL RATE;

ALGORITHMS; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; NEW ZEALAND; SOFTWARE; TACHYCARDIA, VENTRICULAR;

EID: 84870460773     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.07.017     Document Type: Review

References (109)

1. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352(3):225-237.
2. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997, 337(22):1576-1584.
3. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996, 335(26):1933-1940.
4. Cleland J.G.F., Daubert J.-C., Erdmann E., Freemantle N., Gras D., Kappenberger L., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352(15):1539-1549.
5. Buxton A.E., Lee K.L., Hafley G.E., Wyse D.G., Fisher J.D., Lehmann M.H., et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease. Circulation 2002, 106(November (19)):2466-2472.
6. Bourke J.P., Turkington D., Thomas G., McComb J.M., Tynan M. Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators. Heart 1997, 78:581-583. PMID: 9470875.
7. Wathen M.S., DeGroot P.J., Sweeney M.O., Stark A.J., Otterness M.F., Adkisson W.O., et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators. Circulation 2004, 110(October (17)):2591-2596.
8. Irvine J., Dorian P., Baker B., O'Brien B.J., Roberts R., Gent M., et al. Quality of life in the Canadian implantable defibrillator study (CIDS). Am Heart J 2002, 144:282-289. PMID: 12177646.
9. Schron E.B., Exner D.V., Yao Q., Jenkins L.S., Steinberg J.S., Cook J.R., et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002, 105:589-594. PMID: 11827924.
10. Carroll D.L., Hamilton G.A. Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock. Heart Lung 2005, 34:169-178. PMID: 16015221.
11. Poole J.E., Johnson G.W., Hellkamp A.S., Anderson J., Callans D.J., Raitt M.H., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008, 359(10):1009-1017.
12. Volosin K.J., Exner D.V., Wathen M.S., Sherfesee L.O.U., Scinicariello A.P., Gillberg J.M. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling. J Cardiovasc Electrophysiol 2011, 22(3):280-289.
13. Wilkoff B.L., Ousdigian K.T., Sterns L.D., Wang Z.J., Wilson R.D., Morgan J.M. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006, 48(2):330-339.
14. Pacifico A., Hohnloser S.H., Williams J.H., Tao B., Saksena S., Henry P.D., et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 1999, 340(24):1855-1862.
15. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27(5):335.
16. Connolly S.J., Dorian P., Roberts R.S., Gent M., Bailin S., Fain E.S., et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA 2006, 295(January (2)):165-171.
17. Reddy V.Y., Reynolds M.R., Neuzil P., Richardson A.W., Taborsky M., Jongnarangsin K., et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007, 357(26):2657-2665.
18. Kuck K.H., Schaumann A., Eckardt L., Willems S., Ventura R., Delacrétaz E., et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010, 375(9708):31-40.
19. Wilkoff B.L., Williamson B.D., Stern R.S., Moore S.L., Lu F., Lee S.W., et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (primary prevention parameters evaluation) study. J Am Coll Cardiol 2008, 52(7):541-550.
20. Wathen M.S., Sweeney M.O., DeGroot P.J., Stark A.J., Koehler J.L., Chisner M.B., et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001, 104(August (7)):796-801.
21. Herrmann C., von zur MüHen F., Schaumann A., Buss U., Kemper S., Wantzen C., et al. Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators. Pacing Clin Electrophysiol 1997, 20(1):95-103.
22. Sweeney M.O. Overcoming the defects of a virtue. Circulation 2006, 113(June (25)):2862-2864.
23. Michael K.A. The post pacing interval following failed antitachycardia pacing can be used to differentiate between atrial and ventricular tachycardias in ICDs. Heart Rhythm 2011, 8(May (Suppl. 5)).
24. Gulizia M.M., Piraino L., Scherillo M., Puntrello C., Vasco C., Scianaro M.C., et al. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators. Circ Arrhythm Electrophysiol 2009, 2(April (2)):146-153. [Clinical Perspective].
25. Nasir N., Pacifico M.D.A., Doyle M.D.T.K., Earle B.S.N.R., Hardage M.M.L., Henry M.D.P.D. Spontaneous ventricular tachycardia treated by antitachycardia pacing. Am J Cardiol 1997, 79(6):820-822.
26. Wilkoff B.L., Hess M., Young J., Abraham W.T. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004, 15(September (9)):1002-1009.
27. Schaumann A., von zur Mühlen F., Herse B., Gonska B.D., Kreuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation 1998, 97(1):66-74.
28. Saeed M., Neason C.G., Razavi M., Chandiramani S., Alonso J., Natarajan S., et al. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial. J Cardiovasc Electrophysiol 2010, 21(December (12)):1349-1354.
29. Peinado R., Almendral J., Rius T., Moya A., Merino J.L., Martínez-Alday J., et al. Randomized, prospective comparison of four burst pacing algorithms for spontaneous ventricular tachycardia. Am J Cardiol 1998, 82(December (11)):1422-1425. A8-9.
30. Santini M., Lunati M., Defaye P., Mermi J., Proclemer A., del Castillo-Arroys S., et al. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-ATP delivery for painless ICD therapy (ADVANCE-D) trial results. J Interv Card Electrophysiol 2010, 27(2):127-135.
31. Grimm W., Plachta E., Maisch B. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Pacing Clin Electrophysiol 2006, 29(7):759-764.
32. Fries R., Heisel A., Kalweit G., Jung J., Schieffer H. Antitachycardia pacing in patients with implantable cardioverter defibrillators: how many attempts are useful?. Pacing Clin Electrophysiol 1997, 20(1):198-202.
33. Martins R.P., Blangy H., Muresan L., Freysz L., Groben L., Zinzius P.Y., et al. Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study. Europace 2012, 10.1093/europace/eus107.
34. Gasparini M., Menozzi C., Proclemer A., Landolina M., Iacopino S., Carboni A., et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [role of long detection window programming in patients with left ventricular dysfunction, non-ischemic etiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009, 30(November (22)):2758-2767.
35. Khairy P., Mansour F. Implantable cardioverter-defibrillators in congenital heart disease: 10 programming tips. Heart Rhythm 2011, 8(March (3)):480-483.
36. Schoels W., Steinhaus D., Johnson W.B., O'Hara G., Schwab J.O., Jenniskens I., et al. Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging. Heart Rhythm 2007, 4(7):879-885.
37. Sivagangabalan G., Eshoo S., Eipper V.E., Thiagalingam A., Kovoor P. Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2008, 31(September (9)):1095-1099.
38. Ousdigian K., Wilkoff B., Morgan J., Sterns L., Wang Z., Wilson R. ICD patients with a history of spontaneous sustained VT have different outcomes than other secondary or primary prevention patients. Circulation 2005, 112:17.
39. Schwab J.O., Gasparini M., Lunati M., Proclemer A., Kaup B., Santi E., et al. Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III trial. J Cardiovasc Electrophysiol 2009, 20(6):663-666.
40. Schwab J.O., Steinhauss D., Schols W., Jenniskens I., De Groot P. Termination of fast ventricular tachyarryhthmia by antitachycardia pacing in patients with implantable cardioverter defibrillators: comparison of results of the entrust clinical study with the painfree RX II study. Circulation 2005, 112(suppl II).
41. Nanthakumar K., Paquette M., Newman D., Curtis Deno D., Malden L., Gunderson B., et al. Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators. Am Heart J 2000, 139(5):797-803.
42. Rosenqvist M., Beyer T., Block M., den Dulk K., Minten J., Lindemans F. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 jewel ICD investigators. Circulation 1998, 98:663-670. PMID: 9715859.
43. Kettering K., Dörnberger V., Lang R., Vonthein R., Suchalla R., Bosch R.F., et al. Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates. Pacing Clin Electrophysiol 2001, 24(September (9 Pt. 1)):1325-1333.
44. Brugada J., Mont L., Figueiredo M., Valentino M., Matas M., Navarro-López F. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 1998, 9(March (3)):261-268.
45. Glikson M., Swerdlow C.D., Gurevitz O.T., Daoud E., Shivkumar K., Wilkoff B., et al. Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol 2005, 16(7):732-739.
46. Theuns D.A., Rivero-Ayerza M., Goedhart D.M., van der Perk R., Jordaens L.J. Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators. Heart Rhythm 2006, 3(November (11)):1332-1338.
47. Theuns D.A.M.J., Rivero-Ayerza M., Goedhart D.M., Miltenburg M., Jordaens L.J. Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 2008, 10(9):1060-1066.
48. Swerdlow C.D., Chen P.S., Kass R.M., Allard J.R., Peter C.T. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994, 23:1342-1355. PMID: 8176092.
49. Duru F., Bauersfeld U.R.S., Rahn-SchöNbeck M., Candinas R. Morphology discriminator feature for enhanced ventricular tachycardia discrimination in implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2000, 23(9):1365-1374.
50. Anselme F., Mletzko R., Bowes R., Mabo P., Sadoul N., Schoels W., et al. Prevention of inappropriate shocks in ICD recipients: a review of 10,000 tachycardia episodes. Pacing Clin Electrophysiol 2007, 30:S128-S133.
51. Sadoul N., Jung W., Jordaens L., Leenhardt A., Santini M., Wolpert C., et al. Diagnostic performance of a dual-chamber cardioverter defibrillator programmed with nominal settings: a European prospective study. J Cardiovasc Electrophysiol 2002, 13:25-32. PMID: 11843479.
52. Theuns D.A.M.J., Klootwijk A.P.J., Goedhart D.M., Jordaens L.J.L.M. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: RESULTS of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004, 44(December (12)):2362-2367.
53. Russo A.M., Nayak H., Verdino R., Springman J., Gerstenfeld E., Hsia H., et al. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia. Pacing Clin Electrophysiol 2003, 26(12):2289-2295.
54. Wilkoff B.L., Kühlkamp V., Volosin K., Ellenbogen K., Waldecker B., Kacet S., et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: results and technical considerations. Circulation 2001, 103(January (3)):381-386.
55. Friedman P.A., McClelland R.L., Bamlet W.R., Acosta H., Kessler D., Munger T.M., et al. Dual-Chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis. Circulation 2006, 113(June (25)):2871-2879.
56. Dorian P., Philippon F., Thibault B., Kimber S., Sterns L., Greene M., et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 2004, 1:540-547. PMID: 15851216.
57. Srivatsa U.N. Ventricular arrhythmia discriminator programming and the impact on the incidence of inappropriate therapy in patients with implantable cardiac defibrillators. Indian Pacing Electrophysiol J 2007, 7:77-84.
58. Klein G.J., Gillberg J.M., Tang A., Inbar S., Sharma A., Unterberg-Buchwald C., et al. Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol 2006, 17(December (12)):1310-1319.
59. Toquero J., Alzueta J., Mont L., Lozano I.F., Barrera A., Berruezo A., et al. Morphology discrimination criterion wavelet improves rhythm discrimination in single-chamber implantable cardioverter-defibrillators: Spanish register of morphology discrimination criterion wavelet (REMEDIO). Europace 2009, 11(June (6)):727-733.
60. Almendral J., Arribas F., Wolpert C., Ricci R., Adragao P., Cobo E., et al. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (dual chamber and atrial tachyarrhythmias adverse events study) trial. Europace 2008, 10(May (5)):528-535.
61. Gold M.R., Shorofsky S.R., Thompson J.A., Kim J., Schwartz M., Bocek J., et al. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol 2002, 13(November (11)):1092-1097.
62. Lee M.A., Corbisiero R., Nabert D.R., Coman J.A., Giudici M.C., Tomassoni G.F., et al. Clinical results of an advanced SVT detection enhancement algorithm. Pacing Clin Electrophysiol 2005, 28(October (10)):1032-1040.
63. Sweeney M.O. The contradiction of appropriate shocks in primary prevention ICDS: increasing and decreasing the risk of death. Circulation 2010, 122:2638-2641. PMID: 21135359.
64. Boriani G., Occhetta E., Pistis G., Menozzi C., Jorfida M., Sermasi S., et al. Combined use of morphology discrimination, sudden onset, and stability as discriminating algorithms in single chamber cardioverter defibrillators. Pacing Clin Electrophysiol 2002, 25(9):1357-1366.
65. Boriani G., Biffi M., Dall'Acqua A., Martignani C., Frabetti L., Zannoli R., et al. Rhythm discrimination by rate branch and QRS morphology in dual chamber implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2003, 26(January (1 Pt. 2)):466-470.
66. Bailin S.J., Niebauer M., Tomassoni G., Leman R., Photon Investigators Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol 2003, 14(February (2)):144-149.
67. Deisenhofer I., Kolb C., Ndrepepa G., Schreieck J., Karch M., Schmieder S., et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001, 12(February (2)):134-142.
68. Sinha A.-M., Stellbrink C., Schuchert A., MöX B., Jordaens L.U.C., Lamaison D., et al. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. J Cardiovasc Electrophysiol 2004, 15(June (6)):646-652.
69. Theuns D.A., Rivero-Ayerza M., Boersma E., Jordaens L. Prevention of inappropriate therapy in implantable defibrillators: a meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. Int J Cardiol 2008, 125(April (3)):352-357.
70. Berger R.D., Lerew D.R., Smith J.M., Pulling C., Gold M.R. The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2006, 17(July (7)):749-753.
71. Sadoul N., Mletzko R., Anselme F., Bowes R., Schöls W., Kouakam C., et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients. Circulation 2005, 112(August (7)):946-953.
72. Mansour F., Khairy P. Programming ICDs in the modern era beyond out-of-the box settings. Pacing Clin Electrophysiol 2011, 34(4):506-520.
73. Arya A., Haghjoo M., Emkanjoo Z., Dehghani M., Sadr-Ameli M. Does the rate of inappropriate therapy differ in implantable cardioverter-defibrillators from different manufacturers?. J Interv Card Electrophysiol 2006, 17(1):59-63.
74. Weretka S., Michaelsen J., Becker R., Karle C.A., Voss F., Hilbel T., et al. Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems. Pacing Clin Electrophysiol 2003, 26(January (1 Pt. 1)):65-70.
75. Cooklin M., Tummala R.V., Peters R.W., Shorofsky S.R., Gold M.R. Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J 1999, 138(July (1 Pt. 1)):133-136.
76. Goldberger J.J., Horvath G., Donovan D., Johnson D., Challapalli R., Kadish A.H. Detection of ventricular fibrillation by transvenous defibrillating leads: integrated versus dedicated bipolar sensing. J Cardiovasc Electrophysiol 1998, 9(July (7)):677-688.
77. Verga T.A., Gillberg J.M., Greenberg R.M., Deger F.T. True bipolar and integrated bipolar sensing and detection by implantable defibrillators. Pacing Clin Electrophysiol 2011, 34(November (11)):1561-1568.
78. Eckstein J., Koller M.T., Zabel M., Kalusche D., Schaer B.A., Osswald S., et al. Necessity for surgical revision of defibrillator leads implanted long-term. Circulation 2008, 117(May (21)):2727-2733.
79. Kallinen L.M., Hauser R.G., Tang C., Melby D.P., Almquist A.K., Katsiyiannis W.T., et al. Lead integrity alert algorithm decreases inappropriate shocks in patients who have sprint fidelis pace-sense conductor fractures. Heart Rhythm 2010, 7(8):1048-1055.
80. Swerdlow C.D., Gunderson B.D., Ousdigian K.T., Abeyratne A., Sachanandani H., Ellenbogen K.A. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures/clinical perspective. Circulation 2010, 122(October (15)):1449-1455.
81. First clinical experience with an automatic algorithm to prevent inappropriate shocks due to T-wave oversensing in ICDs. Eurospace 2011, 13(Suppl. 1):i47-i82.
82. Investigators T.D.T. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. J Am Med Assoc 2002, 288(December (24)):3115-3123.
83. Olshansky B., Day J.D., Moore S., Gering L., Rosenbaum M., McGuire M., et al. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator?. Circulation 2007, 115(January (1)):9-16.
84. Bardy G.H., Poole J.E., Kudenchuk P.J., Dolack G.L., Kelso D., Mitchell R. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion. Circulation 1993, 87(June (6)):1889-1896.
85. Xie J., Weil M.H., Sun S., Tang W., Sato Y., Jin X., et al. High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation 1997, 96(July (2)):683-688.
86. Schaer B.A., Koller M.T., Sticherling C., Altmann D., Joerg L., Osswald S. Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 2009, 6(December (12)):1737-1743.
87. Brooks L., Zhang Y., Dendi R., Anderson R.H., Zimmerman B., Kerber R.E. Selecting the transthoracic defibrillation shock directional vector based on VF amplitude improves shock success. J Cardiovasc Electrophysiol 2009, 20(September (9)):1032-1038.
88. Kroll M.W., Efimov I.R., Tchou P.J. Present understanding of shock polarity for internal defibrillation: the obvious and non-obvious clinical implications. Pacing Clin Electrophysiol 2006, 29(8):885-891.
89. Yamanouchi Y., Mowrey K.A., Nadzam G.R., Hills D.G., Kroll M.W., Brewer J.E., et al. Effects of polarity on defibrillation thresholds using a biphasic waveform in a hot can electrode system. Pacing Clin Electrophysiol 1997, 20(12):2911-2916.
90. Huang J., KenKnight B.H., Walcott G.P., Walker R.G., Smith W.M., Ideker R.E. Effect of electrode polarity on internal defibrillation with monophasic and biphasic waveforms using an endocardial lead system. J Cardiovasc Electrophysiol 1997, 8(2):161-171.
91. Friedman P.A., Rasmussen M.J., Grice S., Trusty J., Glikson M., Stanton M.S. Defibrillation thresholds are increased by right-sided implantation of totally transvenous implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1999, 22(August (8)):1186-1192.
92. Varma N., Efimov I. Right pectoral implantable cardioverter defibrillators: role of the proximal (SVC) coil. Pacing Clin Electrophysiol 2008, 31(August (8)):1025-1035.
93. Lewandowski M., Sterlinski M., Maciag A., Syska P., Kowalik I., Szwed H., et al. Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming. Europace 2010, 12(September (9)):1245-1250.
94. Sherrid M.V., Daubert J.P. Risks and challenges of implantable cardioverter-defibrillators in young adults. Prog Cardiovasc Dis 2008, 51(3):237-263.
95. Berul C.I., Van Hare G.F., Kertesz N.J., Dubin A.M., Cecchin F., Collins K.K., et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008, 51(17):1685-1691.
96. Koneru J.N., Swerdlow C.D., Wood M.A., Ellenbogen K.A. Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: appropriate programming. Circ Arrhythm Electrophysiol 2011, 4(October (5)):778-790.
97. Do R., Patton K.K. Cardiovascular implantable electronic devices in athletes. Cardiovasc Ther 2010, 28(5):327-336. [Review].
98. Love B.A., Barrett K.S., Alexander M.E., Bevilacqua L.M., Epstein M.R., Triedman J.K., et al. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2001, 12(October (10)):1097-1101.
99. Korte T., Köditz H., Niehaus M., Paul T., Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004, 27(July (7)):924-932.
100. Cron T.A., Schaer B., Osswald S. Implantable cardioverter defibrillator proarrhythmia due to an interaction with "noncompetitive atrial pacing": an algorithm to prevent atrial arrhythmias. Pacing Clin Electrophysiol 2002, 25(November (11)):1656-1659.
101. Viskin S., Fish R. Prevention of ventricular arrhythmias in the congenital long QT syndrome. Curr Cardiol Rep 2000, 2(November (6)):492-497.
102. Pinski S.L., Eguía L.E., Trohman R.G. What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers. Pacing Clin Electrophysiol 2002, 25(November (11)):1612-1615.
103. Friedman P.A., Jalal S., Kaufman S., Villareal R., Brown S., Hahn S.J., et al. Effects of a rate smoothing algorithm for prevention of ventricular arrhythmias: results of the ventricular arrhythmia suppression trial (VAST). Heart Rhythm 2006, 3(May (5)):573-580.
104. Cooper J.M., Sauer W.H., Verdino R.J. Absent ventricular tachycardia detection in a biventricular implantable cardioverter-defibrillator due to intradevice interaction with a rate smoothing pacing algorithm. Heart Rhythm 2004, 1(December (6)):728-731.
105. Moss A.J., Liu J.E., Gottlieb S., Locati E.H., Schwartz P.J., Robinson J.L. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation 1991, 84(October (4)):1524-1529.
106. Viskin S., Alla S.R., Barron H.V., Heller K., Saxon L., Kitzis I., et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996, 28(November (5)):1262-1268.
107. Tavernier R., Gevaert S., De Sutter J., De Clercq A., Rottiers H., Jordaens L., et al. Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001, 85(1):53-56.
108. Lin G., Nishimura R.A., Gersh B.J., Phil D., Ommen S.R., Ackerman M.J., et al. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart 2009, 95(May (9)):709-714.
109. Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001, 104(November (21)):2517-2524.